Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering DrugsHye Won Lee, Carolyn S.P. Lam, Shun Kohsaka et al.|Journal of the American College of Cardiology|2018Cited by 465
Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controlsChing‐Ti Liu, Jennifer A. Brody, Federico Centeno-Cruz et al.|Nature|2019Cited by 338
GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO StudyKristine Færch, Marit E. Jørgensen, Signe S. Torekov et al.|Diabetes|2015Cited by 316
Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose RegulationKristine Færch, Jens J. Holst, Dorte Vistisen et al.|Diabetes|2016Cited by 228
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acidsNicolai J. Wewer Albrechtsen, Jens J. Holst, Kristine Færch et al.|Diabetologia|2018Cited by 118